Virtual reality rehabilitation for spinal muscular atrophy
Part of Brain & nervous system clinical trials.
This study tests a virtual reality rehabilitation program for young people with SMA (spinal muscular atrophy, a genetic muscle-weakening condition). Researchers want to understand if VR-based exercises can help improve function and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have genetically confirmed SMA (a blood or genetic test has confirmed the diagnosis)
- You are between 6 and 18 years old
- You speak English well enough to complete surveys, or someone can help translate
- If you're 6–15 years old, your parent or legal guardian must consent; if 16–18, you can consent yourself
- For some age groups, you must be receiving disease-modifying therapy (a treatment that slows SMA progression)
- You don't have injuries or skin conditions that would prevent you from using a virtual reality device
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses wearable devices (like smartwatches or activity trackers) to monitor movement and motor development in young children with spinal muscular atrophy (SMA), a rare genetic condition affecting muscle strength. The goal is to see if wearables can track disease progression and treatment response better than traditional clinic visits.
This trial tests a new gene therapy called Vesemnogene Lantuparvovec for people with spinal muscular atrophy (SMA). It is designed for patients in low- and middle-income countries who cannot access or did not respond to other treatments. The goal is to see if the therapy is safe and effective in real-world conditions.
This trial tests a new medicine called EXG001-307 for babies with spinal muscular atrophy (SMA) types 1 and 2. The goal is to see if it is safe and helps with muscle strength and breathing.
This trial tests a virtual-reality training system that uses muscle signals to help people regain arm movement after a recent stroke. It may be an option if you had a stroke within the last 2 weeks and have arm weakness.
This study compares two robot-assisted rehabilitation programs to see which one helps children and young adults with spinal muscular atrophy (SMA) improve their movement and function better. You may join if you have SMA (types 1-4), are up to 21 years old, and are already receiving medication for SMA.
This study looks at how muscles work in children and young adults with spinal muscular atrophy (SMA) who are taking or starting SMN-directed therapies (like Evrysdi, Spinraza, or Zolgensma). It aims to understand the body's response to these treatments, which could help improve future care.
Hear when a new Spinal Muscular Atrophy (SMA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.